AQR Arbitrage’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

AQR Arbitrage’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-594,245	Closed	-$8.88M	–	1297
2022 Q4	$8.88M	Buy	+594,245	New	+$8.23M	0.23%	126

AQR Arbitrage's AVEO Position: Q1 2023 in Review

AQR Arbitrage sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 594,245 shares — an estimated $8.88M sold.

AQR Arbitrage first reported a position in AVEO in Q4 2022 and held it in 1 quarter. The position peaked at $8.88M in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

AQR Arbitrage reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
AQR Arbitrage sold 594,245 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $8.88M.
AQR Arbitrage first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2022 and held it in 1 quarter.
AQR Arbitrage's AVEO Pharmaceuticals, Inc. position peaked at $8.88M in Q4 2022.
0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on AQR Arbitrage's 13F filing for Q1 2023, filed 15 May 2023.